Respiratory syncytial virus (RSV) is responsible for a significant proportion of global
morbidity and mortality affecting young children and older adults. In the aftermath of formalin …

Respiratory syncytial virus (RSV) is a significant viral pathogen that causes respiratory
infections in infants, the elderly, and immunocompromised individuals. RSV-related …

In August 2022, a novel henipavirus (HNV) named Langya virus (LayV) was isolated from
patients with severe pneumonic disease in China. This virus is closely related to Mòjiāng …

Various chemical adjuvants are available to augment immune responses to non-replicative,
subunit vaccines. Optimized adjuvant selection can ensure that vaccine-induced immune …

Viral pathogenesis and therapeutic screening studies that utilize small mammalian models
rely on the accurate quantification and interpretation of morbidity measurements, such as …

The emergence of SARS-CoV-2 variants alters the efficacy of existing immunity towards the
viral spike protein, whether acquired from infection or vaccination. Mutations that impact N …

Respiratory syncytial virus (RSV) is a major public health problem that has undergone
significant changes in recent years. First of all, it has become easier to diagnose with highly …

Background A cost-effective Escherichia coli expression system has gained popularity for
producing virus-like particle (VLP) vaccines. However, the challenge lies in balancing the …

In the past decade, new approaches to the discovery and development of vaccines have
transformed the field. Advances during the COVID‐19 pandemic allowed the production of …

Subunit vaccines offer a potential method for vaccine discovery and are a more affordable
and secure alternative to conventional treatments. They do not pose a risk of side effects and …